CRSP vs CTVA · rev $11.6M vs P/E 42, rev $16.91B
Crispr Therapeutics AG (CRSP) versus Corteva Inc (CTVA) — a side-by-side from cached financials, not a winner call.
Crispr Therapeutics AG (CRSP) is a biotechnology company listed on US.
Corteva Inc (CTVA) is a agricultural inputs company listed on US.
Latest reported CRSP revenue for 2026-06-30 was $11.6M. Net income was -$214.1M. CRSP currently screens at market cap $5.42B.
Latest reported CTVA revenue for 2024-12-31 was $16.91B. Net income was $919.0M. Revenue was down 1.8% from 2023-12-31 to 2024-12-31. CTVA currently screens at market cap $51.52B and trailing P/E 41.6.
CRSP currently screens at market cap $5.42B. CTVA currently screens at market cap $51.52B and trailing P/E 41.6.
Not investment advice. Open the CRSP and CTVA stock pages for the full models.
Not investment advice.